[Psychotherapies: what is the impact on the cortical and subcortical levels?].
Cottraux
J
J
Psychiatre des Hôpitaux, Chargé de cours à l'Université Lyon 1, Unité de Traitement de l'Anxiété, Hôpital Neurologique.
D001921:Brain / Q000503:physiopathology*; D003511:Cyclohexanols / Q000627:therapeutic use; D003863:Depression / Q000503:physiopathology* / Q000628:therapy*; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000503:physiopathology* / Q000628:therapy*; D010698:Phobic Disorders / Q000503:physiopathology* / Q000628:therapy*; D011613:Psychotherapy / Q000379:methods*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D000069470:Venlafaxine Hydrochloride
D003511:Cyclohexanols; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride